![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Lung Cancer |
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment
of Advanced Non-small Cell Lung Cancer.
Am J Clin Oncol. 2023 Feb 20. doi: 10.1097/COC.0000000000000985.
PubMed
Abstract available
A Novel Prognostic Score Based on Multiple Quantitative Parameters of Chest CT
for Patients with Synchronous Multiple Primary Lung Cancer: Is Solid Component
Size a Better Prognostic Indicator?
Ann Surg Oncol. 2023 Feb 23. doi: 10.1245/s10434-023-13248.
PubMed
Abstract available
Surgical Approach and Persistent Opioid Use in Medicare Patients undergoing Lung
Cancer Resection.
Ann Thorac Surg. 2023 Feb 15:S0003-4975(23)00138.
PubMed
Abstract available
Lung Cancer: A Frequent Tumor With a Rare Synchronous Metastasis.
Arch Bronconeumol. 2023 Feb 6:S0300-2896(23)00024.
PubMed
Safety, efficacy, and pharmacokinetics of SH-1028 in EGFR T790M-positive advanced
non-small cell lung cancer patients: A dose-escalation phase 1 study.
Cancer. 2023 Feb 22. doi: 10.1002/cncr.34697.
PubMed
Abstract available
Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the
National Cancer Database.
Cancer. 2023;129:860-866.
PubMed
Abstract available
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and
Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal
Metastases.
Clin Cancer Res. 2023;29:775-783.
PubMed
Abstract available
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine
Neoplasms.
Clin Cancer Res. 2023;29:731-741.
PubMed
Abstract available
The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung
Cancer Patients Receiving Immune Checkpoint Inhibitors.
Clin Lung Cancer. 2023 Jan 21:S1525-7304(23)00001.
PubMed
Abstract available
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with
stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK
rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre
phase II o
Eur J Cancer. 2023;183:38-48.
PubMed
Abstract available
Sublobar resection for early-stage lung cancer: the issue of safety margins.
Eur J Cardiothorac Surg. 2023 Feb 22:ezad055. doi: 10.1093.
PubMed
Detection of pretreatment circulating tumor DNA predicts recurrence after
high-dose proton beam therapy for early-stage non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2023 Feb 21:S0360-3016(23)00166.
PubMed
Abstract available
Histologic Subtypes of Non-Small Cell Lung Cancer: Can We Further Personalize
Radiation Therapy?
Int J Radiat Oncol Biol Phys. 2023;115:906-908.
PubMed
Establishing a metastasis-related diagnosis and prognosis model for lung
adenocarcinoma through CRISPR library and TCGA database.
J Cancer Res Clin Oncol. 2023;149:885-899.
PubMed
Abstract available
Case report: identification of EGFR R776H and FANCE R381H germline mutations in a
patient with multiple pulmonary nodules.
J Cancer Res Clin Oncol. 2023;149:921-927.
PubMed
Abstract available
Discovery of potential biomarkers for lung cancer classification based on human
proteome microarrays using Stochastic Gradient Boosting approach.
J Cancer Res Clin Oncol. 2023 Feb 18. doi: 10.1007/s00432-023-04643.
PubMed
Abstract available
Risk mapping of lung cancer: a comprehensive appraisal of published meta-analyses
incorporating Mendelian randomization studies.
J Cancer Res Clin Oncol. 2023 Feb 21. doi: 10.1007/s00432-023-04606.
PubMed
Abstract available
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is
Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung
Cancer.
J Clin Oncol. 2023 Feb 23:JCO2201748. doi: 10.1200/JCO.22.01748.
PubMed
Abstract available
Waiting for Big Changes in Limited-Stage Small-Cell Lung Cancer: For Now, More of
the Same.
J Clin Oncol. 2023 Feb 23:JCO2202316. doi: 10.1200/JCO.22.02316.
PubMed
Abstract available
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung
Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.
J Clin Oncol. 2023 Feb 21:JCO2201989. doi: 10.1200/JCO.22.01989.
PubMed
Abstract available
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO
Living Guideline, Version 2022.3.
J Clin Oncol. 2023 Feb 21:JCO2202783. doi: 10.1200/JCO.22.02783.
PubMed
Abstract available
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO
Living Guideline, Version 2022.3.
J Clin Oncol. 2023 Feb 21:JCO2202782. doi: 10.1200/JCO.22.02782.
PubMed
Abstract available
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among
Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.
JAMA Oncol. 2023;9:206-214.
PubMed
Abstract available
Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced
Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1
Subgroups.
JAMA Oncol. 2023;9:215-224.
PubMed
Abstract available
Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival
Benefit From ICI in Advanced Gastroesophageal Cancer-Reply.
JAMA Oncol. 2023;9:280-281.
PubMed
Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival
Benefit From ICI in Advanced Gastroesophageal Cancer.
JAMA Oncol. 2023;9:280.
PubMed
Response and acquired resistance to MET inhibitors in de novo MET fusion-positive
advanced non-small cell lung cancer.
Lung Cancer. 2023;178:66-74.
PubMed
Abstract available
Systemic treatment and radiotherapy for patients with non-small cell lung cancer
(NSCLC) and HIV infection - A systematic review.
Lung Cancer. 2023;178:75-86.
PubMed
Abstract available
NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients
with metastatic non-small-cell lung cancer.
Lung Cancer. 2023;178:87-95.
PubMed
Abstract available
Safety and tolerability of stereotactic radiotherapy combined with durvalumab
with or without tremelimumab in advanced non-small cell lung cancer, the phase I
SICI trial.
Lung Cancer. 2023;178:96-102.
PubMed
Abstract available
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in
Oncogene-Addicted Lung Cancer.
Lung Cancer. 2023;178:103-107.
PubMed
Abstract available
The impact of impaired tissue fixation in resected non-small-cell lung cancer on
protein deterioration and DNA degradation.
Lung Cancer. 2023;178:108-115.
PubMed
Abstract available
Second-line treatment outcomes after progression from first-line chemotherapy
plus immunotherapy in patients with advanced non-small cell lung cancer.
Lung Cancer. 2023;178:116-122.
PubMed
Abstract available
HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4
targeting-induced low-lactate stress in non-small cell lung cancer.
Oncogene. 2023 Feb 23. doi: 10.1038/s41388-023-02641.
PubMed
Abstract available
RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape.
Oncologist. 2023 Feb 23:oyac264. doi: 10.1093.
PubMed
Abstract available
Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte,
and advanced lung cancer inflammation index biomarkers predicting lung cancer
survival.
PLoS One. 2023;18:e0282206.
PubMed
Abstract available
Symptom severity trajectories and distresses in patients undergoing
video-assisted thoracoscopic lung resection from surgery to the first
post-discharge clinic visit.
PLoS One. 2023;18:e0281998.
PubMed
Abstract available
Health outcomes and healthcare resource utilization among Veterans with stage IV
non-small cell lung cancer treated with second-line chemotherapy versus
immunotherapy.
PLoS One. 2023;18:e0282020.
PubMed
Abstract available
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein.
Proc Natl Acad Sci U S A. 2023;120:e2214921120.
PubMed
Abstract available
lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination
of Notch1.
Proc Natl Acad Sci U S A. 2023;120:e2206694120.
PubMed
Abstract available
Transient visual loss following CT-guided percutaneous core needle biopsy of a
lung lesion.
Thorax. 2023;78:316-317.
PubMed
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by